Analystreport

Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) had its "buy" rating re-affirmed by analysts at Dawson James.

Brainstorm Cell Therapeutics Inc.  (BCLI) 
Last brainstorm cell therapeutics inc. earnings: 11/14 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.brainstorm-cell.com